[HTML][HTML] Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy
Hepatocellular carcinoma (HCC) is the third most frequent cause of tumor-related mortality
and there are an estimated approximately 850,000 new cases annually. Most HCC patients …
and there are an estimated approximately 850,000 new cases annually. Most HCC patients …
Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy
XX Ding, QG Zhu, SM Zhang, L Guan, T Li… - …, 2017 - pubmed.ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the third most frequent cause of tumor-related mortality
and there are an estimated approximately 850,000 new cases annually. Most HCC patients …
and there are an estimated approximately 850,000 new cases annually. Most HCC patients …
[HTML][HTML] Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy
XX Ding, QG Zhu, SM Zhang, L Guan, T Li, L Zhang… - Oncotarget, 2017 - oncotarget.com
Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy |
Oncotarget Online ISSN: 1949-2553 Search: Oncotarget Home Editorial Board Submission …
Oncotarget Online ISSN: 1949-2553 Search: Oncotarget Home Editorial Board Submission …
Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy.
XX Ding, QG Zhu, SM Zhang, L Guan, T Li, L Zhang… - Oncotarget, 2017 - europepmc.org
Hepatocellular carcinoma (HCC) is the third most frequent cause of tumor-related mortality
and there are an estimated approximately 850,000 new cases annually. Most HCC patients …
and there are an estimated approximately 850,000 new cases annually. Most HCC patients …
[引用][C] Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy
XX Ding, QG Zhu, SM Zhang, L Guan, T Li, L Zhang… - Oncotarget, 2017 - cir.nii.ac.jp
Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy
XX Ding, QG Zhu, SM Zhang, L Guan, T Li, L Zhang… - Oncotarget, 2017 - oncotarget.com
Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy |
Oncotarget Online ISSN: 1949-2553 Search: Oncotarget Home Editorial Board Submission …
Oncotarget Online ISSN: 1949-2553 Search: Oncotarget Home Editorial Board Submission …
Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy.
XX Ding, QG Zhu, SM Zhang, L Guan, T Li, L Zhang… - Oncotarget, 2017 - europepmc.org
Hepatocellular carcinoma (HCC) is the third most frequent cause of tumor-related mortality
and there are an estimated approximately 850,000 new cases annually. Most HCC patients …
and there are an estimated approximately 850,000 new cases annually. Most HCC patients …